-
Patients taking dual anti-platelet therapy (DAPT) with aspirin and clopidogrel are at higher risk of bleeding with coronary artery bypass graft surgery (CABG) than those taking aspirin alone.
-
Statins and liver function; dosing timing for thyroxine; rivaroxaban for VTE, DVT, and stroke; echinacea and the common cold; and FDA actions.
-
-
This paper describes the results of a study which compared two energy types, cryoenergy and radiofrequency (RF), for catheter ablation in patients with atrioventricular nodal reentrant tachycardia (AVNRT).
-
Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions.
-
-
Over the last twenty years, the proportion of cardiac-arrest victims in whom pulseless electric activity (PEA) is identified rather than asystole or ventricular fibrillation as the initial ECG finding has been increasing.
-
Gastrointestinal (GI) bleeding is a major complication of dual anti-platelet therapy (DAPT) with aspirin and clopidogrel.
-
New high-sensitivity cardiac troponin assays detect blood levels in many patients with chronic heart failure or ischemic heart disease who do not meet clinical criteria for myocardial infarction.
-
Post-pericardiotomy syndrome (PPS) is relatively common after cardiac surgery, and can result in life-threatening events, such as cardiac tamponade, increased length of stay, readmission to hospital, and significant patient discomfort.